Bain Capital Investors LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 12, 2024), Bain Capital Investors LLC reported 5 stock positions worth $4.7 billion. Its top holding was Cerevel Therapeutics (CERE) at 57.0% of the portfolio, followed by Surgery Partners (SGRY, 25.2%) and Waystar (WAY, 12.8%). Compared with Q1 2024, it opened 1 new position. The biggest buy was a new position in Waystar (WAY).
- Most Recent 13F
- Q2 2026
- Location
- Boston, MA
- CIK
- 0001040508
- Portfolio Value
- $4.7B (Q2 2024)
- SEC Filing
- 0000950123-24-007817 ↗ filed Aug 12, 2024
Holdings Value
Holdings 5 stocks · $4.7B
| CERE Cerevel Therapeutics Holding | 57.02% | 65,679,781 | $2.7B | No change |
| SGRY Surgery Partners Inc. | 25.23% | 49,946,972 | $1.2B | No change |
| WAY Waystar Holding Corp. | 12.77% | 27,980,417 | $601.6M | New |
| AVAH Aveanna Healthcare Holdings | 4.78% | 81,600,880 | $225.2M | No change |
| ADV Advantage Solutions Inc. | 0.20% | 2,890,000 | $9.3M | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| WAY Waystar Holding Corp. | New | 12.77% | +12.77 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $4.8B | BOBS, SGRY, AVAH, KMTS, KLRA |
| Q1 2026 | 7 | $3.3B | BOBS, SGRY, AVAH, KMTS, WAY |
| Q4 2025 | 7 | $4.6B | COHR, SGRY, KMTS, AVAH, WAY |
| Q3 2025 | 6 | $3.4B | SGRY, AVAH, KMTS, WAY, NTNX |
| Q2 2025 | 6 | $3.1B | SGRY, WAY, KMTS, AVAH, NTNX |
| Q1 2025 | 6 | $3.9B | SGRY, WAY, NTNX, KMTS, AVAH |
| Q4 2024 | 5 | $3.5B | SGRY, NTNX, WAY, AVAH, ADV |
| Q3 2024 | 5 | $3.8B | SGRY, NTNX, WAY, AVAH, ADV |
| Q2 2024 | 5 | $4.7B | CERE, SGRY, WAY, AVAH, ADV |
| Q1 2024 | 4 | $4.5B | CERE, SGRY, AVAH, ADV |